Download Uganda country profile

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Unitaid and Uganda
Country Background
Key Indicators
Country
Region4
Total Population, in ‘000 (2015)1
39 032
989 173
GDP per capita, PPP in $ (2015)2
1 851.0
3 714.1
Healthy life expectancy at birth, in years (2015)
54.0
52.3
Under 5 mortality rate, per 1,000 live births (2015)1
54.6
81.3
HIV prevalence (2015)
1
7.1 [6.6 - 7.7]
7.1 [6.6 - 7.6]
New HIV infections among adults 15-49 years old, per 1000 uninfected population
(2014)1
6.0
2.6
TB incidence, per 100 000 population (2014)1
161
281
Malaria incidence, per 1000 population at risk (2013)1
231.8
268.6
3
Unitaid investments in Uganda (2006-2015)
Malaria
24%
Total amount of investments:
$154.3
Million
Unitaid investments, %
TB
1%
HIV
75%
HIV
Malaria
TB
Active Grants5
Core Investment Area
Project
Lead Grantee
Project
Duration
HIV
Demonstrate feasibility of
treating HCV
(co-infection)
Improving access to diagnosis and treatment for hepatitis C in low- and middle-income countries
Medicines sans frontiers
2015 - 2017
HIV diagnostic and monitoring
tools
Accelerating access to innovative point of care (POC) HIV diagnostics Phase 2a
Clinton Health Access Initiative
2014 - 2016
Providing access to viral-load monitoring and early-infant diagnosis by SAMBA
Diagnostics for the Real World
2014 - 2016
Accelerating access to innovative point-of-care (POC) diagnostics for HIV
Clinton Health Access Initiative
2016 - 2020
HIV diagnostics
Implementation of CD4 and viral load testing in decentralized, remote and resource-limited
settings
Medicines sans frontiers
2012 - 2016
Optimal antiretrovirals for HIV
Treatment
Dolutegravir in pregnant mothers and neonates (DolPHIN2 trial)
University of Liverpool
2016 - 2021
Optimal antiretrovirals for HIV
Treatment
Accelerating patient access to optimal antiretrovirals
Clinton Health Access Initiative
2016 – 2019
Paediatric HIV
Innovation in antiretroviral paediatric market access (IPMA)
Clinton Health Access Initiative
2014 - 2016
MALARIA
Malaria diagnostics
Sustainable quality control of rapid diagnostics tests for malaria
Foundation for Innovative New
Diagnostics
2013 - 2017
Treating Severe Malaria
Better treatment for severe malaria (injectable artestunate)
Medicines for Malaria Venture
2013 - 2016
Better treatment for severe malaria (inter-rectal artesunate)
Medicines for Malaria Venture
2013 - 2016
Addressing neglected childhood tuberculosis (STEP-TB)
TB Alliance
2013 - 2016
EXPAND-TB project
WHO-Global TB Programme
2013 - 2016
Paediatric TB
TB diagnostics
1.
2.
3.
4.
5.
World Health Statistics, 2016, available at http://www.who.int/gho/publications/world_health_statistics/2016/Annex_B/en/
The World Bank, 2015, Uganda and and Sub-Saharan Africa region, available at http://data.worldbank.org/indicator/NY.GDP.PCAP.PP.CD
UNAIDS, AIDSinfo, 2015, available at http://aidsinfo.unaids.org/
For all WHO indicators Region refers to th WHO Region-Africa (AFRO), for indicator on GDP per capita Region refers to the World Bank Sub-Saharan Africa, for indicator on HIV prevalence - Region refers to UNAIDS East and Southern
Africa
Including grants that closed 6 months before the date of update.
Last Update January 2017
TB